Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1866601000168119 | naloxegol 12.5 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1866611000168116 | naloxegol 12.5 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| naloxegol 12.5 mg tablet | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| naloxegol 12.5 mg tablet | Is a | naloxegol | true | Inferred relationship | Some | ||
| naloxegol 12.5 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| naloxegol 12.5 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1879601621 | |
| naloxegol 12.5 mg tablet | has intended active ingredient | naloxegol | true | Inferred relationship | Some | 1879601620 | |
| naloxegol 12.5 mg tablet | has Australian BoSS | naloxegol | true | Inferred relationship | Some | 1879601620 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| naloxegol 12.5 mg tablet, 10 | has MPUU | True | naloxegol 12.5 mg tablet | Inferred relationship | Some | 1 |
| naloxegol 12.5 mg tablet, 30 | has MPUU | True | naloxegol 12.5 mg tablet | Inferred relationship | Some | 1 |
| Movantik 12.5 mg tablet | Is a | True | naloxegol 12.5 mg tablet | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR